Description
Announcement of anchor investor allocation for the public issue (IPO) of Corona Remedies Limited.
Summary
BSE has announced the allocation of shares to anchor investors for the Initial Public Offering (IPO) of Corona Remedies Limited. This circular provides details about the anchor investor allocation ahead of the main public issue opening.
Key Points
- Company: Corona Remedies Limited
- Event: Anchor investor allocation for public issue
- Announcement Date: December 5, 2025
- Anchor allocation completed prior to public issue opening
Regulatory Changes
No regulatory changes. This is a standard IPO process announcement.
Compliance Requirements
- Anchor investors must comply with lock-in requirements as per SEBI regulations
- Disclosure requirements for anchor allocation as mandated by SEBI ICDR Regulations
Important Dates
- Anchor Allocation Date: December 5, 2025
- Public issue dates to be confirmed in offer documents
Impact Assessment
This announcement impacts potential investors in Corona Remedies Limited’s IPO. Anchor investor allocation typically provides price discovery ahead of the retail offering and can influence investor sentiment. The allocation details are relevant for market participants assessing the demand and pricing of the public issue.
Impact Justification
Standard IPO anchor allocation announcement for Corona Remedies Limited, relevant for investors tracking new listings